Tempest Therapeutics (TPST)

Tempest Therapeutics (TPST) Financial Statements


Tempest Therapeutics Financial Overview

Tempest Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.721; its P/E ratio is -1.88; Tempest Therapeutics is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -6.41M$ -7.23M$ -7.29M-$ -8.56M
EBITDA$ -6.33M$ -7.14M$ -7.17M-$ -8.36M
Net Income Common Stockholders$ -6.79M$ -7.58M$ -7.64M-$ -8.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.10M$ 17.60M$ 23.35M$ 31.20M$ 42.79M
Total Assets$ 23.99M$ 30.74M$ 37.33M$ 46.09M$ 63.17M
Total Debt$ 21.01M$ 21.48M$ 21.66M$ 22.11M$ 16.71M
Net Debt$ 9.91M$ 3.88M$ -1.69M$ -9.09M$ -26.08M
Total Liabilities$ 25.18M$ 25.73M$ 26.36M$ 27.98M$ 36.40M
Stockholders Equity$ -1.19M$ 5.01M$ 10.96M$ 18.11M$ 26.77M
Cash Flow-
Free Cash Flow$ -6.49M$ -6.51M$ -8.35M-$ -9.18M
Operating Cash Flow$ -6.49M$ -6.39M$ -8.30M-$ -9.07M
Investing Cash Flow-$ -117.00K$ -46.00K-$ -108.00K
Financing Cash Flow$ 21.00K$ 1.19M$ 44.00K-$ 350.00K
Currency in USD

Tempest Therapeutics Earnings and Revenue History

Tempest Therapeutics Debt to Assets

Tempest Therapeutics Cash Flow

Tempest Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis